Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysis
2008

Effects of Salbutamol on Lung Inflammation in Patients

Sample size: 6 publication Evidence: low

Author Information

Author(s): Roca Oriol, Gómez-Ollés Susana, Cruz Maria-Jesús, Muñoz Xavier, Griffiths Mark JD, Masclans Joan R

Primary Institution: Hospital Universitari Vall d'Hebron

Hypothesis

Does salbutamol have anti-inflammatory effects on the lungs of mechanically ventilated patients with acute lung injury?

Conclusion

Inhaled salbutamol significantly decreased airspace acidosis, a marker of inflammation, in patients with acute lung injury.

Supporting Evidence

  • EBC analysis is a noninvasive technique that can be used to monitor ventilated patients.
  • A significant increase in EBC pH was observed after salbutamol administration.
  • Trends toward decreased nitrosative species and 8-isoprostane concentration were detected.

Takeaway

Doctors used a special technique to collect breath samples from patients with lung injury and found that a medicine called salbutamol helped reduce inflammation in their lungs.

Methodology

Exhaled breath condensate was collected before and after administering inhaled salbutamol, measuring various biomarkers.

Potential Biases

Potential bias due to the small cohort and single-dose administration.

Limitations

The study had a small sample size and the biomarkers were at the low end of assay sensitivity.

Participant Demographics

Six patients, median age 56 years, four males and two females, none were current smokers.

Statistical Information

P-Value

0.028

Confidence Interval

7.66 (7.58 to 7.75) versus 7.83 (7.67 to 7.91)

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc6911

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication